Centric Health Corp. (TSE:CRX – Free Report) – Bloom Burton cut their Q4 2024 EPS estimates for Centric Health in a research note issued to investors on Monday, November 11th. Bloom Burton analyst D. Martin now expects that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.02. Bloom Burton also issued estimates for Centric Health’s FY2025 earnings at $0.09 EPS and FY2026 earnings at $0.20 EPS.
Several other analysts have also weighed in on CRX. Stifel Canada lowered shares of Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th. Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a research note on Thursday, August 8th.
Centric Health Price Performance
Featured Stories
- Five stocks we like better than Centric Health
- The 3 Best Retail Stocks to Shop for in August
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- 3 Best Fintech Stocks for a Portfolio Boost
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Use the MarketBeat Excel Dividend Calculator
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
